Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Uisahak ; 18(2): 173-88, 2009 Dec.
Artigo em Coreano | MEDLINE | ID: mdl-20098057

RESUMO

This paper aims to examine the spread of paragonimiasis and the Japanese colonial government's response to it. To consolidate colonial rule, the Japanese colonial government needed medications to cure paragonimiasis. When Dr. Ikeda Masakata invented acid emetine to cure paragonimiasis in Manchuria in 1915, emetine treatment carried the risk of emetine poisoning such as fatigue, inappetence, heart failure, and death. Nonetheless, Japanese authorities forced clinical trials on human patients in colonial Korea during the 1910s and 1920s. The emetine poisoning accident in Yeongheung and Haenam counties in 1927 occurred in this context. The Japanese government concentrated on terminating an intermediary host instead of injecting emetine to repress endemic disease in Japan. However, the Japanese colonial government pushed ahead with emetine injections for healthy men through the Preliminary Bureau of Land Research in colonial Korea in 1917. This clinical trial simultaneously presented the effects and the side effects of emetine injection. Because of the danger emetine injections posed, the colonial government investigated only the actual condition of paragonimiasis, delaying the use of emetine injection. Kobayashi Harujiro(1884-1969), a leading zoologist and researcher of endemic disease for three decades in the Government General Hospital and Keijo Imperial University in colonial Korea, had used emetine while researching paragonimiasis, but he did not play a leading role in clinical trials with emetine injections, perhaps because he mainly researched the intermediary host. Government General Hospital and Keijo Imperial University therefore faced limitations that kept them from leading the research on endemic disease. As the health administration shifted the central colonial government to local colonial government, the local colonial government pressed ahead with emetine injections for Korean patients. Emetine poisoning had something to do with medical power's localization. Nevertheless, the central colonial government still supported emetine injections with funds from the national treasury. The emetine poisoning accident that occurred simultaneously in two different regions resulted from the Japanese colonial government's support. This accident represented the Japanese colonial rule's atrocity, its suppression of hygiene policies, and its disdain for colonial inhabitants. The colonial government sought to accumulate medical knowledge not to cure endemic disease, but to expand the Japanese Empire.


Assuntos
Colonialismo/história , Emetina/história , Doenças Endêmicas/história , Paragonimíase/história , Ensaios Clínicos como Assunto/história , Emetina/intoxicação , Emetina/uso terapêutico , História do Século XX , Experimentação Humana/história , Humanos , Japão , Coreia (Geográfico) , Masculino , Paragonimíase/tratamento farmacológico
2.
Artigo em Coreano | WPRIM (Pacífico Ocidental) | ID: wpr-44556

RESUMO

This paper aims to examine the spread of paragonimiasis and the Japanese colonial government's response to it. To consolidate colonial rule, the Japanese colonial government needed medications to cure paragonimiasis. When Dr. Ikeda Masakata invented acid emetine to cure paragonimiasis in Manchuria in 1915, emetine treatment carried the risk of emetine poisoning such as fatigue, inappetence, heart failure, and death. Nonetheless, Japanese authorities forced clinical trials on human patients in colonial Korea during the 1910s and 1920s. The emetine poisoning accident in Yeongheung and Haenam counties in 1927 occurred in this context. The Japanese government concentrated on terminating an intermediary host instead of injecting emetine to repress endemic disease in Japan. However, the Japanese colonial government pushed ahead with emetine injections for healthy men through the Preliminary Bureau of Land Research in colonial Korea in 1917. This clinical trial simultaneously presented the effects and the side effects of emetine injection. Because of the danger emetine injections posed, the colonial government investigated only the actual condition of paragonimiasis, delaying the use of emetine injection. Kobayashi Harujiro(1884-1969), a leading zoologist and researcher of endemic disease for three decades in the Government General Hospital and Keijo Imperial University in colonial Korea, had used emetine while researching paragonimiasis, but he did not play a leading role in clinical trials with emetine injections, perhaps because he mainly researched the intermediary host. Government General Hospital and Keijo Imperial University therefore faced limitations that kept them from leading the research on endemic disease. As the health administration shifted the central colonial government to local colonial government, the local colonial government pressed ahead with emetine injections for Korean patients. Emetine poisoning had something to do with medical power's localization. Nevertheless, the central colonial government still supported emetine injections with funds from the national treasury. The emetine poisoning accident that occurred simultaneously in two different regions resulted from the Japanese colonial government's support. This accident represented the Japanese colonial rule's atrocity, its suppression of hygiene policies, and its disdain for colonial inhabitants. The colonial government sought to accumulate medical knowledge not to cure endemic disease, but to expand the Japanese Empire.


Assuntos
Humanos , Masculino , Ensaios Clínicos como Assunto/história , Colonialismo/história , Emetina/história , Doenças Endêmicas/história , História do Século XX , Experimentação Humana/história , Japão , Coreia (Geográfico) , Paragonimíase/tratamento farmacológico
3.
Rev Hist Pharm (Paris) ; 50(335): 401-26, 2002.
Artigo em Francês | MEDLINE | ID: mdl-12515278

RESUMO

At the moment when his operas got a European celebrity, Vincenzo Bellini born in 1801 rapidly died in September 1835 after a three weeks digestive illness, with mainly dysenteria. Young and healthy, this unexpected event questioned the authorities in Paris. The post mortem examination showed that the colonic mucosa was covered by numerous ulcers, and that a large abcess existed in the liver. All other parts of the body were absolutely sound. These results came out from the autopsy performed by Adolphe Dalmas (1799-1844), professor agrégé at the Faculty of medicine of Paris, formerly member of the special committee in charge of fighting the cholera in 1831 and 1832, who studied its medical aspects during the epidemic attack in Russia, Poland, Germany and Great Britain. With a wide knowledge in the field of the intestinal pathology, his conclusions established that the death came from an inflammation of the bowel, excluding clearly any touch of cholera or poisoning. Nowadays, it is obvious that this dysenteria syndome associated to such anatomic disorders would belong to the chronic amebic disease. Probably contaminated in 1828, Bellini developed a severe episode in 1830, necessitating a long rest during several months, spent at Moltrasio along the side of the Lake of Como. At the time, he composed La Sonnambula and Norma. In 1833 after staying in London from April to August, he came to Paris preparing a new work I Puritani (The Puritains). At summer time, he usually suffered slight recurring episodes, that he treated by applying vesicatories. For frequent periods, he lived outside Paris in a villa standing along the Seine in Puteaux rented by his British friends the Levys. Early in September 1835, these symptoms came again and and suddenly worsened with pain, fever and loss of rest at night. Deserted and lonely as the Levys often left the villa, his critical condition exhibiting tremendous sufferings led to death on the 23rd of September. During the final days, he was not granted any relevant medical support, except the poor cares given by the Italian physician Montallegri, not authorised at that time to practice in France. As emetine and quinine since 1822 were both available as pure alcaloids, produced by the pharmacist Joseph Pelletier, it is assumed that Bellini might have recovered after an intensive treatment implementing these substances by oral, local and rectal routes (enemas and suppositories). At that time, apart from the academic teaching inherited from Broussais, the tropical practitioners currently used them in the treatment of dysenteria and tropical liver abcesses (Annesley, Segond and Dutroulau), as decocted ipeca roots and cinchona barks. Later on when the amebic disease has gained its proper nosography, the clinicians underlined the dangerous and unpredictable issues of the hyperacute hepatic syndromes, unexpected and occurring by apparently healthy individuals. By 1960, its treatment was still obtained by the emetine derivatives.


Assuntos
Causas de Morte , Doenças do Sistema Digestório/história , Emetina/história , Pessoas Famosas , Música/história , Quinina/história , França , História do Século XIX
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...